ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 033037 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
+6.6%
Revenue CAGR (3yr)
7.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $30M | $31M | +3.0% | +6.6% |
| Operating Expenses | $26M | $28M | $29M | +3.3% | +6.5% |
| Operating Margin | 6.8% | 7.2% | 7.0% | -2.9% | +0.9% |
| Net Income | $2M | $2M | $2M | +0.0% | +7.6% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 19,721 | 20,698 | 19,887 | -3.9% | +0.4% |
| Medicare Day % | 41% | 44% | 43% | -2.6% | +2.5% |
| Medicaid Day % | 1% | 2% | 2% | +48.0% | +47.4% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.6% ($28M → $31M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.6%
This Hospital
+7.6%
State Avg
Latest Margin
7.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | 7.0% |
| FY2024 (proj) | $35M | 7.1% |
| FY2025 (proj) | $37M | 7.2% |